Maynard Nexsen PC
Maynard Nexsen PC
Main Content
Main Menu
Menu
Our Firm
Our Firm
What Sets Us Apart
MPACT
Firm Principles
Pro Bono
Alumni Network
Meet Our Team
Meet Our Team
Search
Attorneys
Executive Committee
Board Members
Office Managing Shareholders
Firm Administration
Capabilities
What We Do
What We Do
Capabilities
Unique Client Service Offerings
Newsroom
Newsroom
What's New
News
Video
Podcasts
Insights
Events
Media Inquiries
Blog
Video
Podcasts
Careers
Careers
Join Our Team
Laterals
Business Support Services
Summer Associates
Open Positions / Career Opportunities
Locations
Locations
Atlanta, GA
Austin, TX
Birmingham, AL
Boston, MA
Charleston, SC
Charlotte, NC
Columbia, SC
Dallas, TX
Denver, CO
Des Moines, IA
Detroit, MI
Greensboro, NC
Greenville, SC
Huntsville, AL
Knoxville, TN
Los Angeles, CA
Miami, FL
Minneapolis, MN
Mobile, AL
Montgomery, AL
Myrtle Beach, SC
Nashville, TN
New York City, NY
Orange County, CA
Orlando, FL
Phoenix, AZ
Portland, ME
Raleigh, NC
San Antonio, TX
San Francisco, CA
Washington, D.C.
Search Icon
Search Button
Newsroom
Episode 257: Biogen’s $2B Investment in North Carolina’s RTP with Nicole Murphy
Share Icon
11.11.2025
Related Capabilities
Health Care
Value-Added Service Offerings
NP Strategy
Sign Up Icon
Sign Up for our Latest Updates
Related Professionals
Matthew B. Roberts
803.253.8286
Email
Maynard Nexsen Attorneys Earn 2025 Mid-South Super Lawyers Distinction
Maynard Nexsen Publishes Guidance for Life Sciences Companies in Bloomberg Law Article Series
Bronshteyn v. Department of Consumer Affairs
and the Potential Cost of a Vigorous Defense in California
David Robinson Featured in Specturm News Interview on North Carolina Pharma 'Boom' Predicted from U.S-Japan Deal
Due Diligence Concerns For the Buy-Side of Life Sciences Transactions
State of the 340B Program
Scroll Left
Scroll Right
Jump to Page
